These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 8280418)

  • 1. Determinants of HIV-related high risk behaviours among young offenders: a window of opportunity.
    Rothon DA; Strathdee SA; Cook D; Cornelisse PG
    Can J Public Health; 1997; 88(1):14-7. PubMed ID: 9094798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus: laboratory surveillance in England and Wales, 1992-2004.
    Gungabissoon U; Balogun MA; Ramsay ME
    Epidemiol Infect; 2007 May; 135(4):541-8. PubMed ID: 16953951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Infection, Injecting Drug Use, and Neuroendocrine Response to Psychological Stress.
    Ownby RL; Waldrop-Valverde D; Kumar AM; Jones D; Fernandez B; Kumar M
    J HIV AIDS; 2019 Sep; 5(2):. PubMed ID: 32039285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topological and Historical Considerations for Infectious Disease Transmission among Injecting Drug Users in Bushwick, Brooklyn (USA).
    Dombrowski K; Curtis R; Friedman S; Khan B
    World J AIDS; 2013 Mar; 3(1):1-9. PubMed ID: 24672745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of direct-acting antivirals on hepatitis C viraemia among people who inject drugs in England; real-world data 2011-2018.
    Bardsley M; Heinsbroek E; Harris R; Croxford S; Edmundson C; Hope V; Hassan N; Ijaz S; Mandal S; Shute J; Hutchinson SJ; Hickman M; Sinka K; Phipps E
    J Viral Hepat; 2021 Oct; 28(10):1452-1463. PubMed ID: 34270172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are there missed opportunities for vaccinating against hepatitis B among people who inject drugs in the UK?
    Njoroge J; Hope VD; O'Halloran C; Edmundson C; Glass R; Parry JV; Ncube F
    Epidemiol Infect; 2019 Jan; 147():e244. PubMed ID: 31364574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal expansion of community-associated meticillin-resistant Staphylococcus aureus (MRSA) in people who inject drugs (PWID): prevalence, risk factors and molecular epidemiology, Bristol, United Kingdom, 2012 to 2017.
    Packer S; Pichon B; Thompson S; Neale J; Njoroge J; Kwiatkowska RM; Oliver I; Telfer M; Doumith M; Buunaaisie C; Heinsbroek E; Hopewell-Kelly N; Desai M; Hope V; Williams OM; Kearns A; Hickman M; Gobin M
    Euro Surveill; 2019 Mar; 24(13):. PubMed ID: 30940316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs.
    Hope VD; Harris RJ; Vickerman P; Platt L; Shute J; Cullen KJ; Ijaz S; Mandal S; Ncube F; Desai M; Parry JV
    Euro Surveill; 2018 Nov; 23(47):. PubMed ID: 30482265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992-2013.
    Hope VD; Harris R; McVeigh J; Cullen KJ; Smith J; Parry JV; DeAngelis D; Ncube F
    J Acquir Immune Defic Syndr; 2016 Mar; 71(3):331-7. PubMed ID: 26361173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with recently acquired hepatitis C virus infection in people who inject drugs in England, Wales and Northern Ireland: new findings from an unlinked anonymous monitoring survey.
    Cullen KJ; Hope VD; Croxford S; Shute J; Ncube F; Parry JV
    Epidemiol Infect; 2015 May; 143(7):1398-407. PubMed ID: 25119383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study.
    Hope VD; McVeigh J; Marongiu A; Evans-Brown M; Smith J; Kimergård A; Croxford S; Beynon CM; Parry JV; Bellis MA; Ncube F
    BMJ Open; 2013 Sep; 3(9):e003207. PubMed ID: 24030866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C infection among injecting drug users in England and Wales (1992-2006): there and back again?
    Sweeting MJ; Hope VD; Hickman M; Parry JV; Ncube F; Ramsay ME; De Angelis D
    Am J Epidemiol; 2009 Aug; 170(3):352-60. PubMed ID: 19546152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients.
    Mohsen AH; Easterbrook PJ; Taylor C; Portmann B; Kulasegaram R; Murad S; Wiselka M; Norris S
    Gut; 2003 Jul; 52(7):1035-40. PubMed ID: 12801963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural surveillance: the value of national coordination.
    McGarrigle CA; Fenton KA; Gill ON; Hughes G; Morgan D; Evans B
    Sex Transm Infect; 2002 Dec; 78(6):398-405. PubMed ID: 12473798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of a hepatitis C virus antibody assay in saliva for epidemiological studies.
    Bello PY; Pasquier C; Gourney P; Puel J; Izopet J
    Eur J Clin Microbiol Infect Dis; 1998 Aug; 17(8):570-2. PubMed ID: 9796656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV infection in injecting drug users attending centres in England and Wales, 1990-1991.
    Noone A; Durante AJ; Brady AR; Majid F; Swan AV; Parry JV; Hart GJ; Connell JA; Perry KR; Joce RE
    AIDS; 1993 Nov; 7(11):1501-7. PubMed ID: 8280418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unlinked anonymous monitoring of HIV prevalence in England and Wales: 1990-92.
    Commun Dis Rep CDR Rev; 1993 Jan; 3(1):R1-11. PubMed ID: 7689016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.